Optimizing Hepatitis B Vaccination Strategies for Patients With Inflammatory Bowel Disease Get access

• Extract

Letter: Enhancing the Rigor of Research on Herpes Zoster Risk in IBD Patients Post-SARS-CoV2: Recommendations for Global and Detailed Analyses—Authors’ Reply Get access

• Extract

Safety of Rotavirus Vaccination in Infants That Were Exposed to Biologics In Utero: A Systematic Review Get access

• Abstract
• Lay summary
• Supplementary data

Addressing the Risks of Respiratory Syncytial Virus for Patients With Inflammatory Bowel Disease in the Era of Novel Vaccines

• Extract

Increased Risk of Herpes Zoster in Adult Patients with Inflammatory Bowel Disease After SARS-CoV2 Infection: A Propensity-Matched Cohort Study

• Abstract
• Supplementary data

Additional COVID-19 Booster Doses Increase Anti-spike Serum Antibody Concentrations Among Patients With Inflammatory Bowel Disease

• Extract

Persistence of Antibodies Six Months after Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel Disease

Reply to “Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination”

• Extract

A Note on Monkeypox for Our Patients With Inflammatory Bowel Disease

• Extract

Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination

• Abstract
• Lay summary

New Pneumococcal Vaccines for Prevention of Invasive Pneumococcal Disease in Adult Patients With Inflammatory Bowel Disease

• Abstract
• Lay summary

Humoral Immunogenicity of 3 COVID-19 Messenger RNA Vaccine Doses in Patients With Inflammatory Bowel Disease

Safety of Immunizations for the Adult Patient With Inflammatory Bowel Disease—A Systematic Review and Meta-analysis

• Abstract

Did You Get My Message? Trends and Predictors of Inflammatory Bowel Disease Patient-to-Provider Electronic Messaging

• Extract

Addressing COVID-19 Vaccine Hesitancy in Patients with IBD

The Development and Initial Findings of A Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)

• Abstract

Ensuring High and Equitable COVID-19 Vaccine Uptake Among Patients With IBD

• Abstract

COVID-19 Vaccination in Patients With Inflammatory Bowel Disease and History of Reaction to Injectable Therapies

• Extract

Barriers to Administering Vaccines in Inflammatory Bowel Disease Centers

• Extract
• Supplementary data

The Impact of Introducing Patient-Reported Inflammatory Bowel Disease Symptoms via Electronic Survey on Clinic Visit Length, Patient and Provider Satisfaction, and the Environment Microbiome

• Extract